Lantern Pharma Inc. (LTRN)
undefined
undefined%
At close: undefined
3.28
-5.34%
After-hours Dec 13, 2024, 04:53 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 174.84K 154.68K 97.42K 3.39K 1.63K -2.54K
Gross Profit -174.84K -154.68K -97.42K -3.39K -1.63K 2.54K
Operating Income -17.88M -14.43M -12.59M -5.91M -2.43M -1.73M
Interest Income 765.39K 204.35K 67.93K - - -
Pretax Income -15.96M -14.26M -12.36M -5.91M -2.43M -1.73M
Net Income -15.96M -14.09M -12.30M -5.91M -2.43M -1.73M
Selling & General & Admin 5.98M 5.83M 5.02M 3.66M 1.48M 1.15M
Research & Development 11.89M 8.60M 7.57M 2.24M 953.18K 572.10K
Other Expenses - -31.55K 160.55K - - -
Operating Expenses 17.88M 14.43M 12.59M 5.91M 2.43M 1.73M
Interest Expense - 204.35K - - - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 17.88M 14.43M 12.59M 5.91M 2.43M 1.73M
Income Tax - -172.81K -67.93K -202.91K -5 2.54K
Shares Outstanding (Basic) 10.84M 10.85M 10.90M 6.22M 6.27M 6.22M
Shares Outstanding (Diluted) 10.84M 10.85M 10.90M 6.22M 6.27M 6.22M
EPS (Basic) -1.47 -1.3 -1.13 -0.95 -0.39 -0.28
EPS (Diluted) -1.47 -1.3 -1.13 -0.95 -0.39 -0.28
EBITDA -15.79M -14.42M -12.27M -5.90M -2.43M -1.73M
Depreciation & Amortization 174.84K 154.68K 97.42K 3.39K 1.63K -2.54K